Harbour Capital Advisors LLC Invests $232,000 in ASP Isotopes Inc. $ASPI

Key Points

• Harbour Capital Advisors LLC made a new investment in ASP Isotopes Inc., acquiring 33,025 shares valued at approximately $232,000.
• The company's stock has shown a significant increase of 8.0% recently, reaching $9.86, with a 52-week high of $11.68 and low of $2.61.
• ASP Isotopes reported a quarterly loss of ($1.03) earnings per share, missing estimates and indicating a negative return on equity of 239.22%.

Harbour Capital Advisors LLC acquired a new position in shares of ASP Isotopes Inc. (NASDAQ:ASPI - Free Report) in the second quarter, according to its most recent filing with the Securities & Exchange Commission. The firm acquired 33,025 shares of the company's stock, valued at approximately $232,000.

Several other large investors have also recently bought and sold shares of ASPI. BNP Paribas Financial Markets acquired a new stake in shares of ASP Isotopes in the fourth quarter valued at approximately $34,000. SBI Securities Co. Ltd. lifted its stake in shares of ASP Isotopes by 84.8% in the 1st quarter. SBI Securities Co. Ltd. now owns 9,370 shares of the company's stock valued at $44,000 after purchasing an additional 4,299 shares during the period. Millennium Management LLC bought a new position in ASP Isotopes in the fourth quarter worth approximately $55,000. Fortitude Advisory Group L.L.C. bought a new position in ASP Isotopes in the first quarter worth approximately $64,000. Finally, ProShare Advisors LLC bought a new position in ASP Isotopes in the fourth quarter worth approximately $67,000. 16.80% of the stock is owned by institutional investors and hedge funds.

ASP Isotopes Stock Down 0.8%

ASPI traded down $0.09 during midday trading on Tuesday, reaching $11.13. 5,898,884 shares of the company were exchanged, compared to its average volume of 3,343,082. The company has a debt-to-equity ratio of 3.53, a quick ratio of 14.56 and a current ratio of 14.72. The company's fifty day moving average price is $9.42 and its 200 day moving average price is $7.40. The company has a market cap of $1.02 billion, a price-to-earnings ratio of -18.17 and a beta of 3.36. ASP Isotopes Inc. has a one year low of $2.61 and a one year high of $11.86.

ASP Isotopes (NASDAQ:ASPI - Get Free Report) last issued its quarterly earnings data on Thursday, August 14th. The company reported ($1.03) EPS for the quarter, missing analysts' consensus estimates of ($0.11) by ($0.92). The company had revenue of $1.20 million for the quarter, compared to the consensus estimate of $1.60 million. ASP Isotopes had a negative return on equity of 239.22% and a negative net margin of 2,181.62%. As a group, analysts expect that ASP Isotopes Inc. will post -0.24 EPS for the current year.

Insider Activity

In other ASP Isotopes news, Director Duncan Moore sold 75,000 shares of the company's stock in a transaction that occurred on Friday, August 29th. The stock was sold at an average price of $9.28, for a total transaction of $696,000.00. Following the transaction, the director owned 994,553 shares in the company, valued at approximately $9,229,451.84. This represents a 7.01% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, COO Robert Ainscow sold 8,438 shares of the business's stock in a transaction that occurred on Monday, September 8th. The stock was sold at an average price of $8.53, for a total value of $71,976.14. Following the completion of the sale, the chief operating officer directly owned 1,411,554 shares in the company, valued at approximately $12,040,555.62. This represents a 0.59% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 245,591 shares of company stock valued at $2,139,790 over the last three months. Corporate insiders own 21.40% of the company's stock.

Analysts Set New Price Targets

Separately, Canaccord Genuity Group reiterated a "buy" rating and issued a $11.00 price target on shares of ASP Isotopes in a report on Wednesday, September 17th. Two equities research analysts have rated the stock with a Buy rating, According to MarketBeat.com, the stock currently has a consensus rating of "Buy" and an average target price of $7.75.

ASP Isotopes Company Profile

ASP Isotopes Inc, a development stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It engages in the production and commercialization of Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. The company is also developing Quantum Enrichment technology to produce Ytterbium-176, Nickel-64, Lithium 6, Lithium7, and Uranium-235.